Data provider Accession Acronym URL
EGAO00000000002 BCGSC
The mandate of the Genome Sciences Centre at BCCA is to advance knowledge about cancer and other diseases, to improve human health through disease prevention, diagnosis and therapeutic approaches, and to realize the social and economical benefits of genomics and informatics research

This data provider is associated with 24 studies:

Study Accessionsort ascending Title
EGAS00001002424 Cell fate mapping of human glioblastoma reveals an invariant stem cell hierarchy pre- and post-treatment
EGAS00001001953 Comprehensive molecular profiling identifies novel genetic drivers and subtypes underlying medulloblastoma
EGAS00001001473 Whole genome and transcriptome analysis of medullary thyroid cancer
EGAS00001001386 Novel genes for Intellectual Disability identified using whole genome sequence and pathway analysis
EGAS00001001310 Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells
EGAS00001001214 Whole genome and transcriptome analysis of anaplastic thyroid carcinoma
EGAS00001001159 The BC Cancer Agency's Personalized Onco-Genomics Project
EGAS00001001025 Comprehensive miRNA Sequence Analysis Reveals Survival Differences in Diffuse Large B-cell Lymphoma Patients
EGAS00001001000 An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup
EGAS00001000952 Dynamics of genomic clones in breast cancer patient xenografts at single cell resolution
EGAS00001000940 Whole genome study of Hurthle cell thyroid carcinoma
EGAS00001000714 Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
EGAS00001000646 The study provides comprehensive access to the set of EGA studies which may be useful as controls.
EGAS00001000554 Recurrent Somatic Mutations of PTPN1 in Primary Mediastinal B cell lymphoma and Hodgkin Lymphoma
EGAS00001000552 Reference epigenomes generated as part of the International Human Epigenomics Consortium (IHEC)